Przeglad Menopauzalny : Impact Factor & More
eISSN: 2299-0038pISSN: 1643-8876
Open AccessShare this on:
Key Metrics
CiteScore 
2.5
SJR
Q3Obstetrics and Gynecology
SNIP
0.86
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Przeglad Menopauzalny
Przeglad Menopauzalny Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | TERMEDIA PUBLISHING HOUSE LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 100 |
| Publication Time | 12 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in Przeglad Menopauzalny ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Przeglad Menopauzalny
Prevalence, intention to use, and factors associated with the decision to use contraceptives among Peruvian women aged 40 to 49 years
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Burden of steatotic liver disease in postmenopausal women: NHANES 2017–2020 insights
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Benign serous cystadenofibroma with multimodal imaging suggestive of malignancy in a symptomatic postmenopausal patient
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Associations between menopause and body image
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Tamoxifen treatment in breast cancer: diagnostic methods for endometrial changes
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Prevalence, intention to use, and factors associated with the decision to use contraceptives among Peruvian women aged 40 to 49 years
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Burden of steatotic liver disease in postmenopausal women: NHANES 2017–2020 insights
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Benign serous cystadenofibroma with multimodal imaging suggestive of malignancy in a symptomatic postmenopausal patient
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Associations between menopause and body image
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
Tamoxifen treatment in breast cancer: diagnostic methods for endometrial changes
- 1 Sep 2025
- Przegla̜d Menopauzalny = Menopause Review
FAQs on Przeglad Menopauzalny
How long has Przeglad Menopauzalny been actively publishing? 
What is the publishing frequency of Przeglad Menopauzalny?
How many articles did Przeglad Menopauzalny publish last year?
What is the eISSN & pISSN for Przeglad Menopauzalny?
What is Citescore for Przeglad Menopauzalny?
What is SNIP score for Przeglad Menopauzalny?
What is the SJR for Przeglad Menopauzalny?
Who is the publisher of Przeglad Menopauzalny?
